Purchase Order 36C24221P0710
- Not listed
- The Department of Veterans Affairs (VA) awarded a $139,200 firm-fixed-price delivery order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide emergency reagents for COVID-19 testing. This order was placed under the VA's Indefinite Delivery/Indefinite Quantity (IDIQ) contract for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII) on the General Services Administration (GSA) Federal Supply Schedule. The contract does not have a set-aside designation and the period of...
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, a large pharmaceutical and medical device manufacturer. The $318,854.57 Blanket Purchase Agreement (BPA) call is for the supply of reagents for the VA's laboratory testing needs. The BPA is part of a larger $12.5 million, 5-year BPA with the VA to provide Alinity diagnostic reagents. Abbott Molecular has also been awarded...
- This federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, is for the provision of Infectious Disease PCR Reagents and Consumables. The contract, valued at $6,665,247.19, is a Delivery Order awarded on March 14, 2022, with a completion date of September 30, 2026. It is a Firm Fixed Price contract funded by the Veterans Integrated Service Network 8, a civilian agency within the Department of Veterans Affairs. The contract does not utilize a set-aside designation,...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $354,218.93 firm fixed price purchase order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for COVID-19 reagents and supplies under the Alinity-M testing platform. This order was placed by the VA Veterans Integrated Service Network 2, which covers facilities in New York and New Jersey. Abbott Molecular is a medical device manufacturer that has provided a range of diagnostic tests, equipment, and...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide histology and cytology reagents. The $290,857.89 contract, which did not utilize a set-aside, has a completion date of November 29, 2019. Abbott Molecular is a manufacturer of medical diagnostic products and has a history of supplying a range of molecular diagnostics equipment, reagents, and testing services...
- This is a federal contract award by the Department of Veterans Affairs (VA) Veterans Health Administration to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the provision of molecular reagents. The contract is a Delivery Order under the GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test Kits, with a Firm Fixed Price of $149,947.60. The contract is not set-aside and has a completion date of October 13, 2018. Abbott Molecular is a manufacturer of diagnostic...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide COVID-19 testing equipment, molecular analyzers, and reagents. The order is under the Veterans Integrated Service Network 15 and has a potential value of $747,456.06 with an end date of October 14, 2023. This delivery order is part of a Blanket Purchase Agreement (BPA) call under the GSA Schedule 65-VII contract...
- This federal contract award is an administrative correction to an existing Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) and Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The BPA, valued at up to $1,312,614.01, is for the procurement of COVID-19 testing equipment, molecular analyzers, and associated reagents with high-volume output capabilities. The contract does not have a set-aside designation. Abbott Molecular, a leading provider of molecular...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) call to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide reagents and optical calibration kits. The contract has a potential value of $319,706.86 and is under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. The contract is not set aside for any particular business type. Abbott Molecular is a manufacturer of molecular diagnostic products and has...
- This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the U.S. Department of Veterans Affairs (VA) to provide laboratory reagents. The contract has a ceiling value of $237,608.36 and is a delivery order under the VA's Invitro Diagnostics, Reagents, Test (FSS-65-VII) Federal Supply Schedule contract. The contract is for a firm fixed price and does not have a set-aside designation. Abbott Molecular is the prime contractor and there is no information...
This federal contract award is for the procurement of REAGENTS by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 2. The contract was awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, on a Firm Fixed Price basis for $116,606.01. The contract does not have a set-aside designation. Abbott Molecular is a medical device and diagnostics manufacturer that has provided a range of products and services to federal agencies, including the VA, Centers for Disease Control and Prevention, and Department of the Army. This includes COVID-19 test kits, reagents for clinical chemistry analyzers, viral load testing, and reagents for HIV and Hepatitis C testing. Abbott Molecular holds several Indefinite Delivery/Indefinite Quantity (IDIQ) contracts and Blanket Purchase Agreements (BPAs) with the VA to supply diagnostic reagents, testing services, and equipment maintenance.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $116.6k | 4/12/21 |